Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.

Mwatelah RS, Lwembe RM, Osman S, Ogutu BR, Aman R, Kitawi RC, Wangai LN, Oloo FA, Kokwaro GO, Ochieng W.

PLoS One. 2015 Jul 24;10(7):e0132287. doi: 10.1371/journal.pone.0132287. eCollection 2015.

2.

Implementation and Operational Research: Correlates of Adherence and Treatment Failure Among Kenyan Patients on Long-term Highly Active Antiretroviral Therapy.

Ochieng W, Kitawi RC, Nzomo TJ, Mwatelah RS, Kimulwo MJ, Ochieng DJ, Kinyua J, Lagat N, Onyango KO, Lwembe RM, Mwamburi M, Ogutu BR, Oloo FA, Aman R.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):e49-56. doi: 10.1097/QAI.0000000000000580.

3.

Genotypic Variability of HIV-1 Reverse Transcriptase Gene from Long-Term Antiretroviral-Experienced Patients in Kenya.

Nzomo TJ, Kitawi RC, Mwatelah RS, Aman R, Kimulwo MJ, Masankwa G, Okendo J, Lwembe RM, Ogutu B, Muigai A, Ochieng W.

AIDS Res Hum Retroviruses. 2015 May;31(5):550-3. doi: 10.1089/AID.2015.0031. Epub 2015 Mar 31.

4.

Characterization of HBV Among HBV/HIV-1 Co-Infected Injecting Drug Users from Mombasa, Kenya.

Kibaya RM, Lihana RW, Kiptoo M, Songok EM, Ng'ang'a Z, Osman S, Ishizaki A, Bi X, Okoth FA, Ichimura H, Lwembe RM.

Curr HIV Res. 2015;13(4):292-9.

PMID:
25613131
5.

HIV-1 subtype diversity based on envelope C2V3 sequences from Kenyan patients on highly active antiretroviral therapy.

Kitawi RC, Nzomo T, Mwatelah RS, Aman R, Kimulwo MJ, Masankwa G, Lwembe RM, Okendo J, Ogutu B, Ochieng W.

AIDS Res Hum Retroviruses. 2015 Apr;31(4):452-5. doi: 10.1089/AID.2014.0306. Epub 2014 Dec 18.

PMID:
25423998
6.

Diversity of HIV type 1 and drug resistance mutations among injecting drug users in Kenya.

Osman S, Lihana RW, Kibaya RM, Ishizaki A, Bi X, Okoth FA, Ichimura H, Lwembe RM.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):187-90. doi: 10.1089/AID.2012.0182. Epub 2012 Sep 18.

PMID:
22856626
7.

Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.

Lihana RW, Lwembe RM, Bi X, Ochieng W, Panikulam A, Palakudy T, Musoke R, Owens M, Ishizaki A, Okoth FA, Songok EM, Ichimura H.

J Clin Virol. 2011 Oct;52(2):123-8. doi: 10.1016/j.jcv.2011.06.014. Epub 2011 Jul 27.

PMID:
21798798
8.

HIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samples.

Lihana RW, Khamadi SA, Lwembe RM, Kinyua JG, Muriuki JK, Lagat NJ, Okoth FA, Makokha EP, Songok EM.

BMC Infect Dis. 2009 Dec 30;9:215. doi: 10.1186/1471-2334-9-215.

9.

The changing trend of HIV type 1 subtypes in Nairobi.

Lihana RW, Khamadi SA, Lwembe RM, Ochieng W, Kinyua JG, Kiptoo MK, Muriuki JK, Lagat N, Osman S, Mwangi JM, Okoth FA, Songok EM.

AIDS Res Hum Retroviruses. 2009 Mar;25(3):337-42. doi: 10.1089/aid.2008.0228.

PMID:
19327052
10.

Active generation and selection for HIV intersubtype A/D recombinant forms in a coinfected patient in Kenya.

Songok EM, Lwembe RM, Kibaya R, Kobayashi K, Ndembi N, Kita K, Vulule J, Oishi I, Okoth F, Kageyama S, Ichimura H.

AIDS Res Hum Retroviruses. 2004 Feb;20(2):255-8.

PMID:
15018715

Supplemental Content

Loading ...
Support Center